After treating the first 40 patients, a reduction in IL-2 dose to 3 MIU on 5 days per week, 2 weeks on followed by 2 weeks off, was necessary because of the onset of high rates of asthenia (55% of grade 3 or 4). This evidence concerns the gene IL2 and asthenia.